Poly Medicure Ltd (POLYMED) Q1FY26 Concall Summary - Jun-2025 Qtr
Performance Overview
- Poly Medicure received the "Medical Device Provider of the Year 2025" award.
- The company appointed Vishal Bhed as Executive Director and PK Gupta as President, Operations and Executive Director.
- Two contract manufacturing agreements were signed with companies based in the US and Hong Kong, focusing on vascular access and pain management products.
- A wholly owned subsidiary was established in Brazil to expand direct market presence and transition from B2B to B2C operations.
- Consolidated revenue for Q1 FY26 reached 403 crores, representing a 5% overall growth.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.